Ebola Bundibugyo Vaccines: Oxford and Moderna Trials Offer Hope

⚠️ Urgent Information — Flash Radio is following this situation in real time Over 9,000 cases and more than 4,300 deaths in the Democratic Republic of the Congo: five months after the outbreak began, no vaccine has yet been approved for Bundibugyo, the virus responsible. Two candidates are currently in trials. ⏱️ 1 min read The facts and recent developments Another approach involves assessing the protection provided by a vaccine already used against Ebola Zaire. But beyond research, public trust will be decisive, notes Emanuele Capobianco, Director of Global Vaccine Safety at Gavi, the Vaccine Alliance. ⚡ Key Points ▸ Over 9,000 cases and more than 4,300 deaths in the Democratic Republic of the Congo: five months after the outbreak began, no vaccine has yet been approved for Bundibugyo, the virus responsible. ▸ But beyond research, public trust will be decisive, notes Emanuele Capobianco, Director of Global Vaccine Safety at Gavi, the Vaccine Alliance. ▸ Another approach involves assessing the protection provided by a vaccine already used against Ebola Zaire. Listen to generalist radios live The daily life is also told live: listen to Jawhara FM, Myra Radio and IFM 100.6 on Flash Radio, no subscription required. 🎶 Jawhara FM live 102.5 MHz — General Public 🎵 Myra Radio live Music 🎬 IFM 100.6 live 100.6 MHz — Entertainment All the Lifestyle section is on All Flash Radio News, and the reading continues with IFM 100.6 on the Flash Radio Live Player. 💬 Flash Chat — Speaking to the listeners And you, what is your view on 'Ebola Bundibugyo Vaccines: Oxford and Moderna Trials Offer Hope'? Listeners comment on this news live in the Flash Chat. Join the live audience chat → Keywords: Civil Security Tech & Innovation Ebola Zaire Emanuele Capobianco 🎙️ Flash Radio Tunisie Production